Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HBB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCNC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP8L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVOP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM48 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MEX3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00441 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SYN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM30A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928565 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR622 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724927 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOMM20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on